Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc.

Overview
Date Founded

1997

Headquarters

6154 NANCY RIDGE DRIVE, SAN DIEGO, CA, 921213223

Type of Company

Public

Employees (Worldwide)

363

Industries

Pharmaceuticals
Hospitals & Patient Services
Biotechnology

Company Description

Corporate Overview Our Focus We are a biopharmaceutical company focused on discovering, developing and commercializing novel drugs for weight management, cardiovascular disease, inflammation and other disorders. In June 2012, the US Food and Drug Administration (FDA) approved our internally discovered drug, BELVIQ® (lorcaserin HCl). Click here for additional information. We are also seeking regulatory approval for BELVIQ in additional territories. Regulatory agencies outside of the US will independently review BELVIQ. In addition to BELVIQ, our internally discovered, oral drug candidates include APD811, an agonist of the prostacyclin receptor intended for the treatment of pulmonary arterial hypertension; temanogrel, an inverse agonist of the serotonin 2A receptor intended for the treatment of thrombotic diseases; APD334, an agonist of the S1P1 receptor intended for the treatment of autoimmune diseases; APD371, an agonist of the cannabinoid receptor 2 intended for the treatment of pain; GPR119 agonists, intended for the treatment of type 2 diabetes; and nelotanserin, an inverse agonist of the serotonin 2A receptor, which we previously studied for the treatment of insomnia

Contact Data
Trying to get in touch with decision makers at Arena Pharmaceuticals, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer, Chief Financial Officer & Director

Vice President, Finance & Chief Financial Officer

Executive Vice President & Chief Financial Officer

Executive Vice President, General Counsel & Secretary

Executive Vice President & Chief Commercial Officer

Executive Vice President & Chief Human Resources Officer

Executive Vice President & Chief Business Officer

Senior Vice President, Clinical Development & Chief Medical Officer

Executive Vice President Technical Operations

Executive Vice President of Human Capital

Board of Directors

Chief Scientific Officer at Cerecor, Inc.

Former Chairman at Intersect ENT, Inc.

Chief Medical Officer at Agilent Technologies, Inc.

President & Chief Executive Officer at GenomeDx Biosciences, Inc.

Chief Executive Officer at Synthetic Genomics, Inc.

Former Managing Director at Citigroup Global Markets, Inc. (Broker)

Chief Operating Officer, Chief Financial Officer & Executive Vice President at Reata Pharmaceuticals, Inc.

Former President, Chief Executive Officer, Chief Financial Officer & Director at Arena Pharmaceuticals, Inc.

Director & Chief Executive Officer at Sensorion SAS

Director, President & Chief Executive Officer at Aimmune Therapeutics, Inc.

Paths to Arena Pharmaceuticals, Inc.
Potential Connections via
Relationship Science
You
Arena Pharmaceuticals, Inc.
Owners & Shareholders
Details Hidden

AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies.

Details Hidden

Avidity Partners Management LP (APM) is a hedge fund manager headquartered in Dallas, Texas founded by Michael David Gregory. APM provides investment advice.

Details Hidden

Founded in 1999, Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. Today, the firm manages approximately $7.3 billion across our strategies.

Recent Transactions
Details Hidden

Arena Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Siegfried Holding AG purchases Arena Pharmaceuticals GmbH /Drug Manufacturing Facility from Arena Pharmaceuticals, Inc.

Details Hidden

Arena Pharmaceuticals, Inc. issued USD Common Stock

Insider Transactions
Details Hidden
Transaction Advisors
Escrow Agent

Advised onArena Pharmaceuticals, Inc. issued USD Common Stock

Auditor

Advised onArena Pharmaceuticals, Inc. issued USD Common Stock

Underwriter

Advised onArena Pharmaceuticals, Inc. issued USD Common Stock

Legal Advisor

Advised onArena Pharmaceuticals, Inc. issued USD Common Stock

Managing Director

Advised onArena Pharmaceuticals, Inc. issued USD Common Stock

Professional

Advised onArena Pharmaceuticals, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner, San Diego at Cooley LLP

Legal Advisor

Partner, San Diego at Cooley LLP

Advisor

Senior Vice President, Head of Clinical Development at Emergent BioSolutions, Inc.

Clients

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

Key Stats and Financials As of 2020
Market Capitalization
$3.93B
Total Enterprise Value
$3.15B
Earnings Per Share
$-7.39
Revenue
$319K
TEVNet Income
-7.78x
Enterprise Value / Sales
9,872.48x
Debt TEV
0.01x
Net Profit
$-405M
Total Equity
$1.08B
Total Debt
$45.6M
EBITDAMargin
-133K%
EBITDA
$-423M
Three Year Compounded Annual Growth Rate Of Revenue
-75.36%
Political Donations
$2,000
2014
$1,000
2008
$500
2008
Investments
Details Hidden

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.

Details Hidden

ChemNavigator.com, Inc. provides cheminformatics product solutions for the management, analysis, and virtual screening of chemical databases. It provides medical related products and services for the researchers in medicinal, computational and synthetic chemistry industry. The company was founded by Tad Hurst and Scott Hutton in 1999 and is headquartered in Milwaukee, WI.

Investors
Details Hidden

Chief Executive Officer, President, and Director at CARA Therapeutics, Inc.

Details Hidden

Co-Founder at CARA Therapeutics, Inc.

Competitors
Regeneron Pharmaceuticals, Inc. Pharmaceuticals - Tarrytown, New York

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Arena Pharmaceuticals, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Arena Pharmaceuticals, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Arena Pharmaceuticals, Inc..